We are live on ! Find out more
OMIC

Singular Genomics Systems, Inc. Common Stock
OMIC

Delisted

OMIC was delisted on the 20th of February, 2025.

Back to rankings

42 hedge funds and large institutions have $13.1M invested in Singular Genomics Systems, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more capital invested

Capital invested by funds: $12.1M → $13.1M (+$964K)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

11% less funds holding

Funds holding: 47 → 42 (-5)

30% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 10

71% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 7

Holders
42
Holders Change
-5
Holders Change %
-10.64%
% of All Funds
0.6%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
2
Increased
7
Reduced
10
Closed
7
Calls
$7K
Puts
–
Net Calls
+$7K
Net Calls Change
+$6K

Top Buyers

Rank Fund Capital Flow
1
QM
QVIDTVM Management
Texas
+$95.1K
2
HighTower Advisors
HighTower Advisors
Illinois
+$55.9K
3
Citadel Advisors
Citadel Advisors
Florida
+$36K
4
Millennium Management
Millennium Management
New York
+$29.6K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$26K

Top Sellers

Rank Fund Capital Flow
1
Bank of Montreal
Bank of Montreal
Ontario, Canada
-$481K
2
BlackRock
BlackRock
New York
-$48.3K
3
WC
Weil Company
California
-$35.6K
4
Renaissance Technologies
Renaissance Technologies
New York
-$20.5K
5
XT
XTX Topco
Cayman Islands
-$16.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
DM
1
Deerfield Management
New York
$2.56M – – –
AVM
2
Arch Venture Management
Illinois
$1.95M – – –
QM
3
QVIDTVM Management
Texas
$1.29M +$95.1K +6,236 +8%
UBS Group
4
UBS Group
Switzerland
$1.14M +$15 +1 +0%
PA
5
Perceptive Advisors
New York
$1.09M – – –
Fidelity Investments
6
Fidelity Investments
Massachusetts
$1.09M – – –
Vanguard Group
7
Vanguard Group
Pennsylvania
$963K – – –
CC
8
Casdin Capital
New York
$681K – – –
BlackRock
9
BlackRock
New York
$380K -$48.3K -3,163 -11%
O
10
OrbiMed
New York
$278K – – –
HighTower Advisors
11
HighTower Advisors
Illinois
$272K +$55.9K +3,667 +26%
Verition Fund Management
12
Verition Fund Management
Connecticut
$257K +$12.7K +834 +5%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$237K – – –
TM
14
Tikvah Management
North Carolina
$163K – – –
TM
15
Triatomic Management
California
$100K – – –
Millennium Management
16
Millennium Management
New York
$90.5K +$29.6K +1,938 +49%
BCM
17
Bridgeway Capital Management
Texas
$62.5K – – –
Citadel Advisors
18
Citadel Advisors
Florida
$60.1K +$36K +2,361 +154%
State Street
19
State Street
Massachusetts
$57.9K – – –
Renaissance Technologies
20
Renaissance Technologies
New York
$57K -$20.5K -1,341 -27%
Squarepoint
21
Squarepoint
New York
$52.4K -$9.28K -608 -15%
Northern Trust
22
Northern Trust
Illinois
$41.3K – – –
WC
23
Weil Company
California
$35.1K -$35.6K -2,334 -51%
Susquehanna International Group
24
Susquehanna International Group
Pennsylvania
$26.3K +$26K +1,704 New
MSA
25
Marino Stram & Associates
Massachusetts
$20.6K – – –
1
2

OMIC Hedge Fund Activity: Q1 2024 in Review

42 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Singular Genomics Systems, Inc. Common Stock (OMIC) for Q1 2024, worth a combined $13.1M — up 8% from $12.1M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of OMIC and 2 opened new positions — a net loss of 5 holders — while 10 trimmed existing stakes and 7 added.

The largest buyer was QVIDTVM Management, adding an estimated $95.1K. The largest seller was Bank of Montreal, exiting entirely with an estimated $481K sold.

  • 42 institutional investors held Singular Genomics Systems, Inc. Common Stock (OMIC) as of Q1 2024, down from 47 in Q4 2023.
  • Funds reported $13.1M of Singular Genomics Systems, Inc. Common Stock stock for Q1 2024, up 8% quarter-over-quarter.
  • 2 funds opened new Singular Genomics Systems, Inc. Common Stock positions in Q1 2024 and 7 closed out, a net change of -5 holders.
  • The largest Singular Genomics Systems, Inc. Common Stock buyer in Q1 2024 was QVIDTVM Management, an estimated $95.1K added.
  • The largest Singular Genomics Systems, Inc. Common Stock seller in Q1 2024 was Bank of Montreal, an estimated $481K sold.

Based on aggregated 13F filings for Q1 2024.